These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Facial dysesthesia & pains in cerebral sclerosis]. KEHRER HE Med Klin; 1958 Nov; 53(46):1982-5. PubMed ID: 13612690 [No Abstract] [Full Text] [Related]
4. Multiple sclerosis; failure of treatment with orally administered digestive enzymes. FRIEDMAN AJ Calif Med; 1957 Jul; 87(1):29-31. PubMed ID: 13446741 [TBL] [Abstract][Full Text] [Related]
5. [Enzyme therapy as a method of preparing trophic ulcers and protractedly nonhealing wounds for dermato-autoplasty]. Grigorian AV; Gostishchev VK; Tolstykh PI Klin Khir (1962); 1971 Sep; 9():1-4. PubMed ID: 4939531 [No Abstract] [Full Text] [Related]
6. [Results in therapy of essential hypertension and cerebral sclerosis with mutan]. SKURSKY J Wien Med Wochenschr; 1953 Jan; 103(5):108. PubMed ID: 13078445 [No Abstract] [Full Text] [Related]
7. [The effects of vasolastine on experimental sclerosis in rats and arteriosclerosis in humans]. HOOGERWERF S Arztl Forsch; 1955 Nov; 9(11):I/540-6. PubMed ID: 13302006 [No Abstract] [Full Text] [Related]
8. [Etiology and epidemiology of cerebral sclerosis]. OBERGASSNER H Med Klin; 1954 Oct; 49(44):1774-6. PubMed ID: 13223381 [No Abstract] [Full Text] [Related]
10. [Some data on the histology of nodular cerebral sclerosis]. SCHWAB F Wien Med Wochenschr; 1960 Mar; 110():228-31. PubMed ID: 14443919 [No Abstract] [Full Text] [Related]
11. [Complementary and alternative therapies for multiple sclerosis]. Schwarz S; Leweling H; Sagstetter BU; Meinck HM Med Monatsschr Pharm; 2008 Mar; 31(3):89-98; quiz 99-100. PubMed ID: 18429530 [No Abstract] [Full Text] [Related]
12. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Schreibelt G; van Horssen J; van Rossum S; Dijkstra CD; Drukarch B; de Vries HE Brain Res Rev; 2007 Dec; 56(2):322-30. PubMed ID: 17761296 [TBL] [Abstract][Full Text] [Related]
13. [The evaluation of multiple sclerosis in health insurance judications; a contribution to the problem of multiple sclerosis and war service injury and multiple sclerosis and trauma]. UHLEMANN HJ Nervenarzt; 1953 Mar; 24(3):118-23. PubMed ID: 13072782 [No Abstract] [Full Text] [Related]
14. [A case of mongolism with lobar cerebral sclerosis]. FATTOVICH G Osp Psichiatr; 1950; 18(3):185-212. PubMed ID: 14807544 [No Abstract] [Full Text] [Related]
15. [On the therapy of cerebral sclerosis]. SCHMIDT B Med Welt; 1960 May; 22():1222-4. PubMed ID: 14443013 [No Abstract] [Full Text] [Related]
16. [Contribution to the therapy of psychological, neuropsychiatric and autonomic dystonia in arterio- and cerebral sclerosis]. GUNTHER W Ther Ggw; 1956 Oct; 95(10):384-5. PubMed ID: 13391816 [No Abstract] [Full Text] [Related]
17. [Invalids under Social Security with nervous system diseases in a city population]. ZieliĆski JJ; Niedzielska K Neurol Neurochir Pol; 1970; 4(5):529-36. PubMed ID: 4320429 [No Abstract] [Full Text] [Related]
18. [Cerebral sclerosis from the viewpoint of the psychiatrist]. Conrad K Dtsch Med J; 1957 Jun; 8(6):299-301. PubMed ID: 13447637 [No Abstract] [Full Text] [Related]
19. [On the problem of medical modification of cerebral sclerosis]. JOB J Munch Med Wochenschr; 1960 Mar; 102():483-4. PubMed ID: 13853154 [No Abstract] [Full Text] [Related]
20. [On the treatment of cerebral sclerosis with complamine]. KESSENS L Med Welt; 1960 Nov; 47():2517-8. PubMed ID: 13752735 [No Abstract] [Full Text] [Related] [Next] [New Search]